Inicio › Sobrepeso › Ohio › Cincinnati
Ensayos clínicos de Sobrepeso en Cincinnati, OH
14 estudios para Sobrepeso buscan participantes en centros de Cincinnati y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
ReclutandoFase 3
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ReclutandoFase 3
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ReclutandoFase 3
- CTI Clinical Research Center, Cincinnati
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
ReclutandoFase 3
- CTI Clinical Research Center, Cincinnati
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ReclutandoFase 2
- CTI Clinical Research Center /ID# 282043, Cincinnati
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ReclutandoFase 2
- CTI Clinical Research Center, Cincinnati
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ReclutandoFase 2
- CTI Clinical Research Center, Cincinnati
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ReclutandoFase 3
- CTI Clinical Research Center, Cincinnati
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutandoFase 3
- Clinical Trial Investigator Clinical Research Center, Cincinnati
- Velocity Clinical Research - Cincinnati, Cincinnati
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
ReclutandoFase 3
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutandoFase 3
- AURORA-2 Clinical Site, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutandoFase 3
- AURORA-1 Clinical Site, Cincinnati
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ReclutandoFase 3
- CTI Clinical Research Center, Cincinnati
Effects of Exercise on Lipids and Endothelial Function in Youth
Reclutando
- Cincinnati Children's Hospital Medical Center, Cincinnati
Ensayos de Sobrepeso en otras ciudades
- San Antonio, TX34 estudios
- Houston, TX33 estudios
- Chicago, IL29 estudios
- Orlando, FL27 estudios
- Dallas, TX23 estudios
- Miami, FL23 estudios
- Washington, DC20 estudios
- Atlanta, GA20 estudios
- Austin, TX19 estudios
- Las Vegas, NV19 estudios
- Jacksonville, FL19 estudios
- New York City, NY19 estudios
Otros estudios en Cincinnati
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer (todos los tipos)26 estudios
- Cáncer de seno24 estudios
- Fallo cardíaco22 estudios
- Cáncer metastásico21 estudios
- Cáncer del colon y del recto20 estudios
- Obesidad20 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer de próstata19 estudios
- Cáncer de ovario18 estudios
- Cáncer de pulmón18 estudios
- Mieloma múltiple17 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.